Secondary pharmaceutical packaging
- GMP-licensed and GDP-compliant operations, FMD serialization on every line
- Cold seal wallet technology, chosen by 90 percent of our clients, with up to 80 percent less energy use
- One partner for design, materials, production, serialization and GDP warehousing
Your secondary packaging deserves a specialist, not a vendor chain
Secondary packaging is where quality, compliance and brand meet. It has to keep the dosage form stable, survive GDP logistics, carry FMD-compliant serialization, guide the patient and reflect the positioning of the molecule behind it. For niche pharma, orphan drugs and high-value therapies there is no room for generic solutions or handovers between five different vendors.
Ecobliss is built for exactly that scenario. We combine tailor-made design, GMP production and GDP warehousing under one roof in Echt. Our 40 specialists run both manual and automated lines, which means we can scale from a small clinical trial batch to full commercial supply without switching partners. Every project is treated as if it were our own, with short lines, direct contact and a strong focus on patient-centric outcomes.
Full scope of secondary pharmaceutical packaging under one roof
As your secondary packaging partner we cover the full scope: wallets, blister cards, cartons, kits, titration packaging, inlay cards, multipanel wallets, clinical trial secondary packaging, child-resistant packaging with Locked4Kids and secondary packaging for medical devices including trays, Tyvek liddings and inlay cards. We handle oral solids, vials, syringes, suppositories and devices.
For moisture-sensitive APIs our cold seal technology is the method of choice for 90 percent of our clients, with water-based solvent-free glue and up to 80 percent lower energy use compared to heat seal. Serialization and aggregation are available on every line, fully FMD-compliant. Controlled substances under Schedule I and II are handled in secured GDP warehousing with blockchain-protected artwork document management.
One partner replaces a chain of four to six suppliers
Most pharma teams lose time and margin by coordinating a chain of four to six suppliers: design studio, material sourcing, carton converter, wallet producer, serialization vendor and logistics. Every handover adds risk, documentation overhead and lead time. Ecobliss replaces that chain with one accountable partner.
Our in-house design team delivers prototypes in 5 to 10 working days and a full packaging assessment within one week. Artwork, proofing and material sourcing run under one change control, one quality system and one point of contact. The result is fewer deviations, faster time to clinic or market and a secondary packaging that actually supports adherence. Adherence packaging formats proven in the market increase therapy adherence by more than 30 percent.
From clinical to commercial, with sustainability built in
Sustainability is not a marketing layer at Ecobliss, it is built into the process. We work with FSC-certified board under license C194323, use water-based solvent-free glue and design wallet formats that reduce material use without compromising protection. For ESG-driven sourcing teams this provides documented, auditable evidence of responsible sourcing.
Combined with GMP licensing, GDP-compliant warehousing, FMD-compliant serialization on every line and validated child-resistant solutions through Locked4Kids, we offer a secondary packaging operation that stands up to the most demanding audits from FDA, EMA and national authorities. You work with one partner, one quality system and one team that knows your product as well as you do.
What you can expect when you engage Ecobliss
Step 1. Packaging assessment within one week
We review your product, regulatory scope and commercial goals. You receive a concrete proposal on format, materials, serialization setup and a clear timeline, typically within one week.
Step 2. Tailor-made design and prototyping in 5 to 10 working days
Our in-house design team develops wallet, carton or kit concepts around your dosage form and patient. Physical prototypes are delivered in 5 to 10 working days for internal review and user testing.
Step 3. GMP production with FMD serialization
We produce on manual and automated lines under a GMP license, with FMD-compliant serialization and aggregation available on every line. Scalable from clinical trial volumes to commercial supply, with no fixed minimum order quantity.
Step 4. GDP warehousing and delivery
Finished goods are stored in GDP-compliant warehousing with controlled substance security and blockchain-protected artwork management. We coordinate the release and delivery into your supply chain as one accountable partner.
Replace your vendor chain with one accountable partner
Call plus 31 475 390 550 or request your packaging assessment and receive a concrete proposal within one week. Ecobliss takes ownership of your secondary pharmaceutical packaging from design to delivery.
Frequently asked questions about secondary pharmaceutical packaging
Is Ecobliss GMP licensed and GDP compliant?
Yes. Ecobliss operates under a GMP license for secondary pharmaceutical packaging and runs GDP-compliant warehousing. FMD serialization and aggregation are available on every production line.
Do you fill primary blisters?
No. Ecobliss focuses on secondary pharmaceutical packaging, which is the layer around the blister. We do not fill primary blisters. Our scope includes wallets, blister cards, cartons, kits, titration packaging, inlay cards, multipanel wallets and clinical trial secondary packaging.
What is the difference between cold seal and heat seal in secondary packaging?
Cold seal is a sealing technique, not a blister type. It uses a water-based, solvent-free adhesive and requires up to 80 percent less energy than heat seal. Around 90 percent of our clients choose cold seal wallet technology, especially for moisture-sensitive APIs.
Can you handle controlled substances and clinical trial packaging?
Yes. We are set up for Schedule I and II controlled substances in secured GDP warehousing and we run secondary packaging for clinical trials, scalable from small trial batches up to commercial launch under the same quality system.
Is Locked4Kids a validated child-resistant solution?
Yes. Locked4Kids is our patented child-resistant packaging, certified for both EU and US markets. It is designed as a secondary packaging format that protects children without creating friction for elderly or less dexterous patients.
Do you have a minimum order quantity?
No. There is no fixed minimum order quantity. Our combination of manual and automated lines allows us to serve clinical trial batches and mid-size commercial volumes equally well, which fits high-value, low-mid volume and orphan drug portfolios.
How fast can you deliver a prototype and packaging assessment?
A packaging assessment is typically delivered within one week. Physical prototypes follow within 5 to 10 working days, depending on complexity and material availability.
Contact the team
Or send a message
One moment please, loading calendar...
